Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.
about
The roles of motilin and ghrelin in gastrointestinal motilityPharmacological interventions for non-ulcer dyspepsiaPharmacological interventions for non-ulcer dyspepsiaReview article: current treatment options and management of functional dyspepsiaCurrent issues on safety of prokinetics in critically ill patients with feed intoleranceEffects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trialEffect of atilmotin, a motilin receptor agonist, on esophageal, lower esophageal sphincter, and gastric pressuresGastroparesis: current concepts and management.Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives.Basic and clinical pharmacology of new motility promoting agents.Review article: current and emerging therapies for functional dyspepsia.Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.Diabetic gastroparesis: Therapeutic options.Oral erythromycin and symptomatic relief of gastroparesis: a systematic review.The enteric nervous system III: a target for pharmacological treatment.Pharmacotherapy of gastro-oesophageal reflux disease in children: focus on safety.Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consultersInfluence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptyingDiet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia.Pathophysiology as a basis for understanding symptom complexes and therapeutic targets.Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction?Treatment options for patients with severe gastroparesisNew management approaches for gastroparesis.Treatment of gastroparesis: a multidisciplinary clinical review.Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia.Recent developments in gastrointestinal motility.Can small non-peptide motilin agonists force a breakthrough as gastroprokinetic drugs?Dysaccommodation of the stomach: therapeutic nirvana?The Rome III Classification of dyspepsia: will it help research?Methods to assess gastric motility and sensation.Pathophysiology and management of gastroparesis.Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient.Review article: endpoints used in functional dyspepsia drug therapy trials.Emerging drugs for functional dyspepsia.Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.Functional dyspepsia and gastroparesis: one disease or two?Overlap of functional dyspepsia and GERD--diagnostic and treatment implications.Current management strategies and emerging treatments for functional dyspepsia.Review article: the role of gastrointestinal hormones in the treatment of delayed gastric emptying in critically ill patients.A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water.
P2860
Q21296834-2198FF9A-B226-4173-83C6-7B9B26E3F394Q24234257-52547B3F-3100-4DE3-93C2-52362821C327Q24244245-2CE8E0E1-E4F6-4F83-ABF2-ED33AF40D3C9Q26825651-E18E6BB4-115D-4F31-8C28-A88F0A354936Q26992006-2A8B227C-6019-4E66-935A-24A73A849225Q28346269-B608E0DD-D921-4448-8802-E9AED378FBB5Q33703880-7E8AE482-0FFE-47F8-B31F-4CA20F319EEBQ33781620-CEB406EB-7F23-42CA-99F4-70FD125FAE18Q34344032-03F875D9-941E-4C7E-8638-A94D7CAA44B5Q34453951-E6BF8CE0-5CC6-4563-91A7-85CBB6973DABQ34553942-00BC1302-28EC-4223-95C6-D383A5B374C7Q34893529-39C0E36B-98AC-4D7D-BDB5-7326DB9ABE6EQ35054446-118ECB05-8DFD-4E1F-B13C-E552AF5528C4Q35068003-C006B35A-98AC-4701-9F79-B542F5C3DDAAQ35163567-4B67D993-AFC1-4023-8859-5E9A844D8F3FQ35194467-D070819D-B2C5-4597-8CFC-D25C225B08AFQ35596859-D62381D8-4886-40C7-B9E1-23AD630B038EQ35597269-5609E2BA-5A6E-4F13-8AF9-0E079B868561Q35612104-173E8A9A-8112-4DFC-AAE6-4EA0280F4C73Q35746810-60E4AB98-19E4-4839-8FBC-EF0A27769A5EQ35761270-35178783-30AE-4161-BBFC-6AFF5F073431Q35953930-9D3DB037-309A-44F1-BCE8-EE3FA05A1AD2Q36285947-3D5BB08D-70E9-45D2-8E64-A549BC76EFE3Q36428532-8D421029-3C2D-4008-BE45-3F72483FE44CQ36455905-6B545D1F-EFB5-4632-9B4D-8679830E260DQ36510664-4042CD37-D9E4-4E02-B5F2-198F28564275Q36619739-1AE43214-C2D2-404A-8C45-4A46CD1B882BQ36715884-91B9A85F-9A3D-4841-B17F-F92556412058Q37157123-D66F4FC2-EE89-4276-A860-0793BAB7C1EBQ37212857-10267E81-559A-4D60-8FD2-0153058E81F0Q37436502-307CF310-83E3-49D0-B123-A93A1C806D70Q37686926-0165A7CD-1438-4A30-A72F-FB62FF028334Q37827564-414DD5D6-67A8-4A9F-A65D-B58252F3A676Q37854060-21B94C41-5898-4E3D-BFE6-24092763E0E0Q37854748-D6B0E40E-69CC-4807-ACE2-87FD84E4F214Q38060504-BEBAA3B9-D012-4E77-9B8D-F2EB59F24242Q38072281-CF486F92-445B-4816-AB33-4248C031A805Q38079140-4356C72E-18FF-4B43-B8F2-2507DACB80AFQ38123557-FF788256-28C2-48B0-9F7F-0EEEC1FBDE70Q38133838-F8E6C010-9806-46CF-BA88-0B565D9FEC06
P2860
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Failure of a motilin receptor ...... lind placebo-controlled trial.
@en
Failure of a motilin receptor agonist
@nl
type
label
Failure of a motilin receptor ...... lind placebo-controlled trial.
@en
Failure of a motilin receptor agonist
@nl
prefLabel
Failure of a motilin receptor ...... lind placebo-controlled trial.
@en
Failure of a motilin receptor agonist
@nl
P2093
P2860
P1476
Failure of a motilin receptor ...... lind placebo-controlled trial.
@en
P2093
Brinkhoff H
Ducrotte P
Fumagalli I
Mathias JR
P2860
P304
P356
10.1046/J.1365-2036.2000.00868.X
P407
P577
2000-12-01T00:00:00Z